Mitchell Stephen Ray
SEC insider (Form 3/4/5 filer). CIK 0001802653. Director at Vanda Pharmaceuticals Inc. (VNDA). 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 4, 2026. Located in WASHINGTON, DC.
Companies Mitchell Stephen Ray has filed insider reports for
- Vanda Pharmaceuticals Inc. (VNDA): Director
Mitchell Stephen Ray
CIK: 0001802653
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (40.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (40.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (20.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VNDA
Vanda Pharmaceuticals Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 4, 2026VNDA
Vanda Pharmaceuticals Inc.
AwardDirect41.6K shares- - May 18, 2026VNDA
Vanda Pharmaceuticals Inc.
GiftDirect25.8K shares- - Jun 13, 2025VNDA
Vanda Pharmaceuticals Inc.
SaleDirect7K shares at avg. $4.59$32K - Jun 5, 2025VNDA
Vanda Pharmaceuticals Inc.
AwardDirect59.2K shares- - Nov 14, 2024VNDA
Vanda Pharmaceuticals Inc.
SaleDirect5K shares at avg. $5.17$26K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 4, 2026 | VNDA Vanda Pharmaceuticals Inc. | Award | 41,600 | - | $0 | Direct |
| May 18, 2026 | VNDA Vanda Pharmaceuticals Inc. | Gift | 25,836 | - | $0 | Direct |
| Jun 13, 2025 | VNDA Vanda Pharmaceuticals Inc. | Sale | 7,000 | $4.59 | $32,130 | Direct |
| Jun 5, 2025 | VNDA Vanda Pharmaceuticals Inc. | Award | 59,225 | - | - | Direct |
| Nov 14, 2024 | VNDA Vanda Pharmaceuticals Inc. | Sale | 5,000 | $5.17 | $25,863 | Direct |
1-5 of 5 transactions